US President Trump announced agreements with nine major pharmaceutical companies to lower prescription drug prices in the US, aligning them with those in other wealthy nations. These deals will impact Medicaid pricing and introduce “most-favoured-nation” pricing for new drugs across all markets. Companies also committed to a direct-to-consumer platform and offered discounts.
Related Posts
Pakistan’s Champions Trophy dream ‘ended’ by India: Rizwan
Pakistan captain Mohammad Rizwan conceded that his team’s hopes of winning the Champions Trophy had ended following a defeat to India. Rizwan expressed disappointment in […]
Don’t wait for ‘right time’! How 5-yr delay in investment can cost you – explained
Procrastinating on investing due to fear of market timing is a common pitfall, costing individuals significant wealth over time. Professionals cannot reliably time the market, […]
Why Jaire Alexander is stepping away from football after joining Eagles in shocking twist
Star cornerback Jaire Alexander is taking a break from football. He needs to focus on his health. This comes after a recent trade to the […]